JENBURKT PHARMACEUTICALS LTD. Share Price

JENBURKT PHARMACEUTICALS LTD. Share Price

BSE: 524731
|
Pharmaceuticals
₹ 1,051.15
-₹26.40 (-2.45%)
1D
Last updated 24 Jul, 2026, 15:43 IST

JENBURKT PHARMACEUTICALS LTD. Share Price Today

As of 25 Jul 2026, JENBURKT PHARMACEUTICALS LTD. share price is ₹1,051.15. The stock opened at ₹1,055.55, compared to its previous close of ₹1,077.55. During today's trading session, JENBURKT PHARMACEUTICALS LTD. share price moved in the range of ₹1,040.60 to ₹1,077.70, with an average price of ₹1,059.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹944.00 and a high of ₹1,364.90.

₹1,040.60
2.45% down today
₹1,077.70
1D LOW
1D HIGH

JENBURKT PHARMACEUTICALS LTD. Returns Calculator

Circuit
L
H
₹840.95
₹1,261.35
52-week
L
H
₹944.00
₹1,364.90
Mkt Cap Cr
463.90
P/E
13.69
P/B
2.41
ROE
17.63%
D/E
0.01
ROCE
23.20%
Div. Yield
1.97%
EPS(TTM)
78.71
Turnover
0.83
EV/EBITDA
8.40
Net Margin
0.00%
Op. Margin
0.00%
ROA
15.37%
Quick Ratio
0.00
Curr. Ratio
4.23
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Jenburkt Pharma has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Jenburkt Pharma appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.963.3111.27%0.0014.95%423.360.92%0.4543.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3079.3616.3316.77%0.4016.14%97.210.12%0.6413.72

JENBURKT PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹151.69₹141.97₹136.75₹123.98
Other Income₹6.72₹4.67₹5.12₹4.95
Total Revenue₹158.41₹146.63₹141.87₹128.93
Total Expenses₹114.48₹111.46₹109.01₹99.06
Profit Before Tax₹43.93₹35.18₹32.86₹29.87
Tax₹11.87₹9.20₹8.26₹7.57
Profit After Tax₹32.06₹25.98₹24.61₹22.30
EPS - Basic₹72.65₹58.86₹53.90₹48.58
EPS - Diluted₹72.65₹58.86₹53.90₹48.58

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹32.06₹25.98₹24.61₹22.30
Income before WC changes₹40.85₹34.60₹31.33₹27.62
Change in Assets-₹2.88-₹18.12-₹0.65-₹14.49
Change in Liabilities₹3.37-₹0.10-₹5.40₹3.70
Change in WC₹0.49-₹18.22-₹6.05-₹10.79
Cash flow from Operations₹27.91₹8.12₹17.05₹9.27
Cash flow from Investing-₹17.04-₹0.58₹2.62-₹1.20
Cash flow from Financing-₹7.62-₹7.08-₹21.04-₹5.53
Total Cash Flow₹3.24₹0.47-₹1.37₹2.54
Cash (Start of the year)₹4.13₹3.66₹5.03₹2.49
Cash (End of the year)₹7.36₹4.13₹3.66₹5.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹139.65₹55.37₹60.72₹67.05
Current Assets₹56.53₹109.73₹81.09₹75.90
Total Assets₹196.19₹165.10₹141.81₹142.95
Current Liabilities₹18.82₹16.38₹15.76₹21.28
Net Current Asset₹37.71₹93.35₹65.33₹54.62
Non-Current Liabilities₹5.59₹3.78₹3.66₹4.29
Equity Capital₹171.78₹144.94₹122.39₹117.38
Total Equity & Liabilities₹196.19₹165.10₹141.81₹142.95
* All values are in INR Crore
Qty
Bid
1
1051.15
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
33.95
Neutral
ATR (14)
29
Neutral
STOCH(9,6)
11.8
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
19.81
Bullish
UO(9)
32.66
Neutral
ROC(12)
-4.21
Bearish
WillR(14)
-88.82
Bullish
Period
Simple value
Exponential vaue
5D
1075.03
1071.96
10D
1085.51
1082.9
20D
1098.86
1097.16
50D
1132.89
1108.96
100D
1085.23
1106.36

About JENBURKT PHARMACEUTICALS LTD.

JENBURKT PHARMACEUTICALS LTD. Share Price
ISIN
INE354A01013
Sector Market Cap
₹ 463.9 Cr

Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and healthcare products. The Company offers pharmaceutical products for various therapeutic areas, including analgesic and antipyretics, anthelmintics, anti-arthritics, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer products, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets, Topcal-M Tablets, Powergesic, ZIX P Tablet, and others. The Company's manufacturing plant is in Sihor, Gujarat.

JENBURKT PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: JENBURKT PHARMACEUTICALS LTD. reported revenue of ₹179.04 crore in FY26 vs ₹158.41 crore in FY25. It showed an increase of 13.02% on a yearly basis.
  • Operating Profit: JENBURKT PHARMACEUTICALS LTD. reported an operating profit of ₹46.52 crore in FY26 vs ₹43.93 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
  • Net Profit: JENBURKT PHARMACEUTICALS LTD. reported a net profit of ₹34.74 crore in FY26 vs ₹32.06 crore in FY25. It showed an increase of 8.36% on a yearly basis.

JENBURKT PHARMACEUTICALS LTD. Quarterly Result Highlights

  • JENBURKT PHARMACEUTICALS LTD. reported revenue of ₹48.98 crore in Mar 2026, compared with ₹44.84 crore in Dec 2025, representing an increase of 9.23% on a quarter-on-quarter (QoQ) basis.
  • JENBURKT PHARMACEUTICALS LTD. reported an operating profit of ₹13.71 crore in Mar 2026, compared with ₹8.30 crore in Dec 2025, representing an increase of 65.18% on a quarter-on-quarter (QoQ) basis.
  • JENBURKT PHARMACEUTICALS LTD. reported a profit of ₹10.85 crore in Mar 2026, compared with ₹5.93 crore in Dec 2025, reflecting an increase of 82.97% on a QoQ basis.
  • The earnings per share (EPS) of JENBURKT PHARMACEUTICALS LTD. stood at ₹72.65 during Mar 2026.
Know more
Promoters
46.62%
FII
0.00%
Other DII
0.12%
Retail and other
53.26%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
JENBURKT PHARMACEUTICALS LTD. Share Price
JENBURKT PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on JENBURKT PHARMACEUTICALS LTD. Share Price